The Hospital Creu Roja in Palma de Mallorca takes another step forward in its commitment to the latest technology. This time with the introduction of a Holmium laser technology with Moses effect for the treatment of Benign Prostatic Hyperplasia (BPH) and urinary lithiasis.
Dr. Parejo with his extensive experience and commitment to medical excellence, has led the implementation of this technology in the Hospital Creu Roja, achieving the first prostatectomy intervention by Holmium laser with Moses effect, in the private sector of the Balearic Islands.
The incorporation of the system has been promoted by Dr. Parejo, who assures that it will provide greater precision and effectiveness to the surgical treatment, offering better results to these patients, especially in the reduction of the risk of bleeding and surgical time.
Prostatic hyperplasia is one of the most frequent pathologies in men and is directly related to aging, negatively affecting the quality of life of these patients, causing them difficulty in urination and may even reach the point of being unable to urinate and requiring the placement of a bladder catheter.
Dr. Parejo expressed his enthusiasm about incorporating this technology into the therapeutic arsenal: “We are excited about the incorporation of this technological advance and the positive impact it will have on our patients, improving not only surgical outcomes but also the ability to offer early recovery to daily activity with long-term results. Our commitment is to provide state-of-the-art treatments that improve the quality of life of those who rely on us for their medical care”.
The Hospital Creu Roja prides itself on its commitment to state-of-the-art technology, providing patients with access to the latest innovations in the field of medicine.
The introduction of Holmium laser technology based on the Moses effect reinforces its commitment to excellence in medical care.
Below are 3 news items from local media coverage: